Research and Treatment of ALL in 2025
In order to receive the certificate of participation, you are required to fill out the registration form.
Registration link
Thursday, January 9th, 2025
01:30 PM (GMT)
05:00 PM (Tehran Time)
Join Zoom Meeting:
https://howardcollege-edu.zoom.us/j/99249872538
Meeting ID: 992 4987 2538
Passcode: TUMS-2025
Dr. Hagop Kantarjian
Chair, Leukemia Department, MD Anderson Cancer Center, USA
Dr. Hagop Kantarjian is Chair of the Leukemia Department at MD Anderson Cancer Center in Houston, Texas. He is a fellow in health care policies at the Baker Institute at Rice University. His research focuses on translational-clinical developmental therapeutics in leukemia. Over the past 4 decades, he has made numerous contributions that improved patient prognosis and survival across the leukemia entities, with over 2,400 peer reviewed publications. In addition to his 40+ year career as a leukemia researcher, he has been involved in health care policies, and published extensively on issues related to the Affordable Care Act (ObamaCare), health care as a human right, cancer drug prices, 340B, HPV vaccines, and others.
Dr. Saeid Rezaei Jouzdani
Associate professor, Hematology and Oncology, Internal Medicine Deparment, Kermanshah University of Medical Sciences, Iran
(Moderator)
Dr. Marjan Yaghmaie
Professor, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, Head of Leading House for Iran-North America Academic Partnerships, Tehran University of Medical Sciences, Iran
(Facilitator)